期刊文献+

腹腔镜胆囊切除术前应用帕瑞昔布对术后镇痛的影响 被引量:3

Pre-emptive analgesic effect of parecoxib in laparoscopic cholecystectomy
下载PDF
导出
摘要 目的观察帕瑞昔布在腹腔镜胆囊切除术(LC)术前应用对术后镇痛的影响。方法择期全麻LC患者60例,随机均分为三组:A组术前30~45min静注帕瑞昔布40mg,B组手术结束关腹时静注帕瑞昔布40mg,C组麻醉诱导时静注曲马多100mg。记录患者术后安静时疼痛VAS评分,并观察恢复情况。结果 A组清醒后即刻疼痛VAS评分显著高于B、C两组(P<0.05)。A、B组排气时间显著短于C组(P<0.05)。B组下床时间显著短于A组(P<0.05),进食时间明显短于C组(P<0.05)。A、B组不良反应显著少于C组(P<0.05)。结论术前应用帕瑞昔布40mg对LC未显示出超前镇痛作用,术后应用帕瑞昔布与曲马多超前应用镇痛效果相当,不良反应减少。 Objective To observe whether parecoxib administered in laparoscopic cholecystectomy (LC) could play a role of preemptive analgesia. Methods Sixty patients scheduled for LC were divided into three groups, the which IV dosing schedules as following: parecoxib 40 mg 30-45 rain before the surgery(group A) ; parecoxib 40 mg at wound closure(group B) ; tramadol 100 mg at induction(group C). Pain scores and recovery station were recorded. Results Higher pain scores were observed in group A than in group 13 and group C at 0 h (P(0. 05) ; side-effcets in group A and group B were significantly reduced compared with the group C(P〈0. 05). Condusion Parecoxib is lack of pre-emptive analgesic effect in LC, postoperative administration of parecoxib have the same analgesic effect with preemptive use of tramadol, but less adverse reactions.
出处 《临床麻醉学杂志》 CAS CSCD 北大核心 2012年第12期1184-1186,共3页 Journal of Clinical Anesthesiology
关键词 帕瑞昔布 超前镇痛 术后疼痛 腹腔镜胆囊切除术 Parecoxib Preemptive analgesia Postoperative pain Laparoscopiccholecystectomy (LC)
  • 相关文献

参考文献5

  • 1Vadivelu N,Mitra S,Narayan D. Recent advances in postoperative pain management[J].Yale Journal of Biology and Medicine,2010,(01):11-25.
  • 2Tr(o)ster A,Sittl R,Singler B. Modulation of remifentanilinduced analgesia and postinfusion hyperalgesia by parecoxib in humans[J].Anesthesiology,2006,(05):1016-1023.
  • 3Ehrlich K,Plate S,Stroff T. Peptidergic and cholinergic neurons and mediatorsin peptine-induced gastuoprotcction:role of cyclooxygenase-2[J].American Journal of Physiology,1998,(5 Pt 1):955-964.
  • 4Brodner G,Gogarten W,Van Aken H. Efficacy of intravenous paracetamol compared to dipyrone and parecoxib for postoperative pain management after minor-to-intermediate surgery.:a randomised,double-blind trial[J].European Journal of Anaesthesiology,2011,(02):125-132.
  • 5叶治,夏萍萍,王锷,罗慧,潘韫丹,郭曲练.不同超前镇痛时点应用帕瑞昔布钠对妇科手术后的镇痛效果[J].临床麻醉学杂志,2011,27(2):151-153. 被引量:52

二级参考文献10

  • 1王云姣,程智刚,孙志华,王锷,郭曲练.氯诺昔康预注的腹腔镜胆囊切除术后超前镇痛效果[J].临床麻醉学杂志,2006,22(2):106-107. 被引量:34
  • 2吴新民,岳云,张利萍,王俊科,艾登滨,于布为,薛张纲,黄文起.术后镇痛中帕瑞昔布钠对吗啡用量的节俭作用和安全性—前瞻性、多中心、随机、双盲、安慰剂对照、平行分组研究[J].中华麻醉学杂志,2007,27(1):7-10. 被引量:367
  • 3Kelly DJ, Ahmad M, Brull SJ. Preemptive analgesia i: physio logical pathways and pharmacological modalities. Can J Anaesth, 2001, 48:1000-1010.
  • 4Tang J, I.i S, White PF, et al. Effect of parecoxib, a novel intravenous cyclooxygenase type 2 inhibitor, on the postoper-ative opioid requirement and quality of pain controL. Anes-thesiology, 2002, 96:1305-1309.
  • 5Malan TP Jr, Marsh G, Hakki SI, el al. Parecoxib sodium, a parenteral cyclooxygenase2 selective inhibitor, improves morphine analgesia and is opioid sparing following total hip arthroplasty. Anesthesiology, 2003,98:950-956.
  • 6Mamnez V, Belbachir A, Jaber A, et al. The influence of timing of administration on the analgesic efficacy of parecoxib in orthope-dic surgery. Anesth Analg, 2007, 104:1521-1527.
  • 7Talley J J, Bertenshaw SR. Brown DL, el al. N-[[(5-methyl 3-phenylisoxazol-4-yl)-phenyl] sulfonyl]propanamide, sodium salt, parecoxib sodium: A potent and selective inhibitor of COX 2 for parenteral administration. J Med Chem, 2000, 43, 1661-1663.
  • 8Barton SF, Langeland FE, Snabes MC, et al. Efficacy and safety of intravenous parecoxib sodium in relieving acute post-operative pain following gynecologic laparotomy surgery. An-esthesiology, 2002, 97:306-314.
  • 9Ott E,Nussmeier NA, Duke PC, et al. Efficacy and safety of the cyclooxygenase 2 inhibitors parcoxib and valdcoxib in pa tients undergoing coronary artery bypass surgery. J Thorac Cardiovasc Surg, 2003,125:1481-1492.
  • 10封宇飞,雷静,吕俊玲,李可欣,傅得兴.特异性环氧酶-2抑制剂——帕瑞昔布[J].中国临床药理学杂志,2003,19(3):207-210. 被引量:64

共引文献51

同被引文献19

引证文献3

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部